Intralesional cidofovir for recurrent respiratory papillomatosis in children.
暂无分享,去创建一个
[1] C. Derkay. Recurrent Respiratory Papillomatosis , 2001, The Laryngoscope.
[2] E. De Clercq,et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine] , 1998, Journal of medical virology.
[3] J. Mulliken,et al. Spastic Diplegia as a Complication of Interferon Alfa‐2a Treatment of Hemangiomas of Infancy , 1998, The Journal of pediatrics.
[4] B. Kuppermann,et al. Intravenous Cidofovir for Peripheral Cytomegalovirus Retinitis in Patients with AIDS , 1997, Annals of Internal Medicine.
[5] R. Smith,et al. Recurrent respiratory papillomatosis. , 1996, Pediatric clinics of North America.
[6] C. Desloovere,et al. Treatment of severe recurrent laryngeal papillomatosis by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (Cidofovir®) , 1996 .
[7] E. De Clercq. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. , 1996, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie.
[8] G. Singleton,et al. Adjuvant Drug Strategies in the Treatment of Recurrent Respiratory Papillomatosis , 1995, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[9] P. Rutgeerts,et al. Successful treatment of a squamous papilloma of the hypopharynx‐esophagus by local injections of (S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine , 1995, Journal of medical virology.
[10] Richard J. H. Smith,et al. Acyclovir in the Treatment of Recurrent Respiratory Papillomatosis , 1994, The Annals of otology, rhinology, and laryngology.
[11] P. Rutgeerts,et al. Successful treatment of human papillomavirus (HPV) associated giant squamous papilloma of the hypopharynx and esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) , 1994 .
[12] R. Mcglennen,et al. Pilot trial of ribavirin for the treatment of laryngeal papillomatosis , 1993, Head & neck.
[13] R. Hruban,et al. Sites of Predilection in Recurrent Respiratory Papillomatosis , 1993, The Annals of otology, rhinology, and laryngology.
[14] J. C. Martin,et al. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. , 1992, Molecular pharmacology.
[15] B. Steinberg,et al. Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. , 1992, Archives of otolaryngology--head & neck surgery.
[16] H. Kashima,et al. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-n1 , 1991 .
[17] R. Gelber,et al. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial. , 1988, The New England journal of medicine.
[18] V. F. Righthand,et al. Persistence of echovirus 6 in cloned human cells , 1985, Journal of virology.